Lucas W. Buchanan - 27 Jul 2021 Form 4 Insider Report for Silk Road Medical Inc

Role: COO/CFO
Signature: /s/Mhairi Jones, by power of attorney
Issuer symbol: N/A
Transactions as of: 27 Jul 2021
Net transactions value: -$248,037
Form type: 4
Filing time: 29 Jul 2021, 19:41:15 UTC
Previous filing: 12 Jul 2021
Next filing: 31 Aug 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SILK	Common Stock	Options Exercise	$4,800	+3,000	+1.6%	$1.60^*	189,192	27 Jul 2021	Direct
transaction	SILK	Common Stock	Options Exercise	$71,900	+3,595	+1.9%	$20.00	192,787	28 Jul 2021	Direct	F1
transaction	SILK	Common Stock	Sale	$161,454	-3,595	-1.9%	$44.91	189,192	28 Jul 2021	Direct	F1, F2
transaction	SILK	Common Stock	Options Exercise	$124,370	+4,021	+2.1%	$30.93	193,213	28 Jul 2021	Direct	F1
transaction	SILK	Common Stock	Sale	$180,586	-4,021	-2.1%	$44.91	189,192	28 Jul 2021	Direct	F1, F2
transaction	SILK	Common Stock	Sale	$107,067	-2,384	-1.3%	$44.91	186,808	28 Jul 2021	Direct	F2, F3
holding	SILK	Common Stock						13,518	27 Jul 2021	Buchanan Grandchildren's Irrevocable Trust	F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SILK	Option (right to buy)	Options Exercise	$0	-3,000	-2.2%	$0.000000	135,409	27 Jul 2021	Common Stock	3,000	$1.60	Direct	F5
transaction	SILK	Option (right to buy)	Options Exercise	$0	-3,595	-7.3%	$0.000000	45,448	28 Jul 2021	Common Stock	3,595	$20.00	Direct	F1, F6
transaction	SILK	Option (right to buy)	Options Exercise	$0	-4,021	-12%	$0.000000	28,154	28 Jul 2021	Common Stock	4,021	$30.93	Direct	F1, F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020.
F2	This transaction was executed in multiple trades at price ranging from $43.97 to $46.01. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3	The sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 11, 2020.
F4	These shares are held directly by the Buchanan Grandchildren's Irrevocable Trust, for which the Reporting Person serves as a co-trustee.
F5	All of the shares subject to this option are fully vested and exercisable as of the date hereof.
F6	One forty-eighth of the shares subject to the option shall vest on May 3, 2019 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F7	One forty-eighth of the shares subject to the option shall vest on April 1, 2020 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.